ask="8.34"
ask_size="500"
average_daily_volume="9784"
bid="0.35"
bid_size="100"
book_value="2.22"
change="+0.06"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-2.29"
change_From_52_week_low="0.80"
change_in_percent="+1.79%"
close="3.41"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.74"
ebitda="-19.08M"
eps_estimate_current_year="-1.80"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.70"
ex_dividend_date="N/A"
float_shares="1799000"
high="3.47"
high_52_weeks="5.70"
last_trade_date="3/6/2017"
last_trade_price="3.41"
last_trade_size="200"
last_trade_time="3:57pm"
low="3.32"
low_52_weeks="2.61"
market_capitalization="40.07M"
moving_average_200_day="3.93"
moving_average_50_day="3.33"
name="Nexvet Biopharma plc"
notes="N/A"
one_year_target_price="8.00"
open="3.32"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.33%"
percent_change_from_50_day_moving_average="+2.54%"
percent_change_from_52_week_high="-40.18%"
percent_change_from_52_week_low="+30.65%"
previous_close="3.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.51"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11752000"
short_ratio="8.86"
stock_exchange="NGM"
symbol="NVET"
volume="8524"
weeks_range_52="2.61 - 5.70"
